Skip to main content

Table 2 Brevican expression and the clinicopathological characteristics of 60 patients with malignant glioma.

From: The role of brevican in glioma: promoting tumor cell motility in vitro and in vivo

Cases

Brevican expression

Brevican expression

P value

positive cases (%)

negative cases (%)

Age

 ≤50

25 (78.1)

7 (21.9)

0.10

 >50

16 (57.1)

12 (42.9)

 

Gender

 Male

22 (73.3)

8 (26.7)

0.58

 Female

19 (63.3)

11 (36.7)

 

Histological grade

 I

6 (40.0)

9 (60.0)

0.01

 II

9 (60.0)

6 (40.0)

 

 III

12 (80.0)

3 (20.0)

 

 IV

14 (93.3)

1 (6.7)

 

Degree of differentiation

 Well

15 (50.0)

15 (50.0)

0.005

 Poorly

26 (86.7)

4 (13.3)

Â